SCHEMBL8901817

SCHEMBL8901817

COc1ccc(OC)c2c1COC(C(=O)OCc1ccc([N+](=O)[O-])cc1)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.48
MAPT P10636 4/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 2/20 0.43
PDE7A Q13946 1/20 0.43
PDE3A Q14432 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MITF O75030 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
ATM Q13315 1/20 0.42
LMNA P02545 1/20 0.41
NTSR1 P30989 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8901763 0.82 HTT (0.46) HTTMAPTALDH1A1HPGDRAB9A
SCHEMBL18318470 0.81 TDP1 (0.51) MAPTALDH1A1HPGDRAB9ATDP1
SCHEMBL8901856 0.77 LMNA (0.41) HTTMAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL8903509 0.76 TDP1 (0.47) MAPTALDH1A1HPGDRAB9ATDP1
SCHEMBL27461289 0.75 KDM4E (0.51) HTTMAPTALDH1A1HPGDRAB9A
SCHEMBL8901784 0.71 TDP1 (0.46) HTTMAPTALDH1A1HPGDRAB9A
SCHEMBL8527470 0.71 CYP1A2 (0.47) HTTALDH1A1HPGD
SCHEMBL11618583 0.71 ALDH1A1 (0.46) HTTMAPTALDH1A1HPGDRAB9A
SCHEMBL10543683 0.70 TDP1 (0.55) MAPTALDH1A1HPGDRAB9ATDP1
SCHEMBL8902384 0.70 HTT (0.42) HTTMAPTALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593970-A ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING BIOCHEM PHARMA INC. (CA) 1997-01-14 US disclosed
EP-0533744-A1 HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS BIOCHEM PHARMA INC. (CA) 1993-03-31 EP disclosed
WO-1991019725-A2 HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS BIOCHEM PHARMA INC. (CA) 1991-12-26 WO disclosed